Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
SPRO
#3193
Spero Therapeutics, Inc. Common Stock
2.1
7
-0.46%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
-0.46%
Monthly Change
-8.05%
6 month change
+10.15%
Year Change
+178.21%
Previous Close
2.1
8
Open
2.1
7
Bid
Ask
Low
2.1
7
High
2.1
7
Volume
8
Markets
US Stock Market
Healthcare
SPRO
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
54.52 M
55.9 M
55.91 M
56.28 M
56.34 M
—
Valuation ratios
Enterprise value
-3.24 M
4.69 M
-8.63 M
132 M
57.3 M
185.36 M
Price to earnings ratio
16.75
-0.81
-0.56
-2.96
-2.38
-6.71
Price to sales ratio
0.67
1.16
0.87
3.26
2.55
7.85
Price to cash flow ratio
4.04
-2.37
1.82
4.95
1.66
6.05
Price to book ratio
0.21
1.21
0.17
0.89
0.74
3.01
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.13
0.19
0.18
0.03
0.14
0.53
Return on equity %
0.26
0.45
0.41
0.05
0.28
1.19
Return on invested capital %
113.69
—
—
—
195.47
—
Gross margin %
100
100
100
100
100
400
Operating margin %
138.04
144.41
250.78
17.22
145.46
557.88
EBITDA margin %
—
—
—
—
—
—
Net margin %
126.96
138.85
236.06
11.98
135.65
522.53
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
2.68
2.19
2.56
3.97
3.83
12.56
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.09
0.12
0.06
0.2
0.09
0.48
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0
0
—
—
—
—
Long term debt to total equity ratio
0
0
—
—
—
—
Per share metrics
Operating cash flow per share
0.24
-0.43
-0.07
-0.32
-0.31
-1.13
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
1.41
0.98
0.88
0.56
0.86
3.28
Net current asset value per share
2.43
1.99
1.35
1.06
0.93
5.32
Tangible book value per share
1.21
0.85
0.61
0.59
0.47
2.52
Working capital per share
1.52
1.08
0.82
0.79
0.69
3.38
Book value per share
1.21
0.85
0.61
0.59
0.47
2.52
News
Spero Therapeutics: Tebipenem’s FDA Path Supports A Speculative Buy (NASDAQ:SPRO)
Keutzer, Spero Therapeutics COO, sells $44k in shares
Spero Therapeutics CEO sells $207k in stock
GSK's Q4 Earnings & Sales Beat Estimates, Stock Up on '26 Outlook
Spero Therapeutics announces board resignation and SEC investigation closure
GSK files NDA resubmission for Spero’s tebipenem HBr antibiotic
Spero Therapeutics earnings beat by $0.26, revenue fell short of estimates
Spero therapeutics CEO Rajavelu sells $95k in stock
Disney, Brookfield, Nu Holdings and more set to report earnings Thursday
Spero Therapeutics, Inc. (SPRO) Presents at IDWeek 2025 - Slideshow (NASDAQ:SPRO) 2025-10-22
Spero Therapeutics stock surges after positive Phase 3 UTI drug data
Best Momentum Stock to Buy for October 10th